Dynavax technologies corporation

Major-Pharmaceuticals

DVAX


2929 Seventh Street
Berkeley , CA 94710

Executive/
Director

Price

  • Last Close
  • $ 12.95
    $ +0.05 0.39 %
    Jan 3, 2025
  • 52-Week High/Low
  • $14.98 - $9.9
  • YTD
  • 0%

  • Trading Volume
  • 80,038
  • Market Cap Full
  • $ 1.7B
  • Shares Outstanding
  • 129.3M
    Oct 31, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 50.6% 6.2% -20.1% -5% 120.9% -23% -7.8% -11.2% 1.5% -
Q2 62.2% -18.9% -46.4% 4% 0.2% 16.1% 31.7% -6.5% - -
Q3 122.8% -19.7% -11.7% 8% 95% -17.1% 14.3% 0.6% - -
Q4 -19.6% -22.1% 63.7% 3.5% -26.8% 1.9% -6.7% -0.6% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 1.5% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -84%373%-51%-37%-23%216%-24%31%-9%1%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.56 -0.63 -0.62 -0.15 0.01 0.22 -0.19
Q2 0.41 -0.63 -0.66 -0.53 0.02 0.87 0.03
Q3 0.38 -0.65 -0.49 -0.15 -0.24 0.43 0.10
Q4 0.43 -0.64 -0.39 0.15 0.78 0.45 -
A 1.8 -2.6 -2.2 -0.8 0.6 2 -0.06

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 64 86.2 113.3 124.9 127.7
Jun 62.3 65.1 92.2 114.6 126.3 128.5
Sep 62.7 65.2 109.5 114.8 126.5 128.8
Dec - 83.9 110.2 120 127.6 129.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 4.4 2.9 0.2 0.2 0.6
Fixed Asset Turnover 17.2 11.3 1.3 1 0.4
Total Asset Turnover 0.7 0.4 0.1 0.1 -
Leverage
Debt Ratio - - 0.6 0.9 0.6
Debt – Equity Ratio - - 3.1 22.4 1.6
Interest Coverage -31.6 2.4 -9.7 -7.5 -25.5
Equity multiplier 0.1 0.2 0.6 4.5 0.4